Blunted opiate modulation of prolactin response in smoking men and women

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 1, 2010, Pages 1-5

  Shaw, Darcy ^a   al'Absi, Mustafa ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Dopamine; Opioids; Prolactin; Reward; Smoking

Indexed keywords

DOPAMINE; NALTREXONE; NICOTINE; OPIATE; PLACEBO; PROLACTIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOOD; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; STIMULUS; TOBACCO DEPENDENCE;

ADULT; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; PLACEBOS; PROLACTIN;

EID: 77249154515     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.11.016     Document Type: Article

References (44)

1. Ahmed S.H., Koob G.F. Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) 2005, 180:473-490.
2. al'Absi M. Hypothalamic-pituitary-adrenocortical responses to psychological stress and risk for smoking relapse. Int J Psychophysiol 2006, 59:218-227.
3. al'Absi M. Stress and addiction: biological and psychological mechanisms 2007, Academic Press/Elsevier, London.
4. al'Absi M., Hatsukami D., Davis G.L. Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology (Berl) 2005, 181:107-117.
5. al'Absi M., Lovallo W.R., McKey B.S., Pincomb G.A. Borderline hypertensives produce exaggerated adrenocortical responses to mental stress. Psychosom Med 1994, 56:245-250.
6. al'Absi M., Lovallo W.R., McKey B., Sung B.H., Whitsett T.L., Wilson M.F. Hypothalamic-pituitary-adrenocortical responses to psychological stress and caffeine in men at high and low risk for hypertension. Psychosom Med 1998, 60:521-527.
7. al'Absi M., Wittmers L.E., Hatsukami D., Westra R. Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke. Psychosom Med 2008, 70:928-935.
8. Arnsten A.F., Berridge C., Segal D.S. Stress produces opioid-like effects on investigatory behavior. Pharmacol Biochem Behav 1985, 22:803-809.
9. Bassareo V., De Luca M.N., Di Chiara G. Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex. Psychopharmacology (Berl) 2007, 191:689-703.
10. Ben-Jonathan N., Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001, 22:724-763.
11. Benwell M.E., Balfour D.J., Anderson J.M. Smoking-associated changes in the serotonergic systems of discrete regions of human brain. Psychopharmacology (Berl) 1990, 102:68-72.
12. Buydens-Branchey L., Branchey M., Hudson J., Rothman M., Fergeson P., McKernin C. Serotonergic function in cocaine addicts: prolactin responses to sequential d,l-fenfluramine challenges. Biol Psychiatry 1999, 4:1300-1306.
13. Cannon C.M., Bseikri M.R. Is dopamine required for natural reward. Physiol Behav 2004, 81:741-748.
14. Chretien M., Seidah N.G. Chemistry and biosynthesis of pro-opiomelanocortin. ACTH, MSH's, endorphins and their related peptides. Mol Cell Biochem 1981, 34:101-127.
15. Debeljuk L., Lasaga M. Tachykinins and the control of prolactin release. Peptides 2006, 27(11):3007-3019.
16. Demarest K.T., Moore K.E., Riegle G.D. Acute restraint stress decreases tuberoinfundibular dopaminergic neuronal activity: evidence for a differential response in male versus female rats. Neuroendocrinology 1985, 41:504-510.
17. Denef C., Andries M. Evidence for paracrine interaction between gonadotrophs and lactotrophs in pituitary cell aggregates. Endocrinology 1983, 112:813-822.
18. Di Chiara G., et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 2004, 47:227-241.
19. Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000, 80:1523-1631.
20. Fu Y., Matta S.G., Brower V.G., Sharp B.M. Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: an in vivo microdialysis study. J Neurosci 2001, 21:8979-8989.
21. Grosvenor C.E., Mena F. Effect of suckling upon the secretion and release of prolactin from the pituitary of the lactating rat. J Anim Sci 1971, 32:115-136.
22. Grunder G., Wetzel H., Schlosser R., Anghelescu I., Hillert A., Lange K., Hiemke C., Benkert. Neuroendocrine response to antipsychotics: effects of drug type and gender. Biol Psychiatry 1999, 45:89-97.
23. Kam K., Park Y., Cheon M., Son G., Kim K., Ryu K. Effects of immobilization stress on estrogen-induced surges of luteinizing hormone and prolactin in ovariectomized rats. Endocrine 2000, 12(3):379-387.
24. Khachaturian H., Lewis M.E., Haber S.N., Akil J., Watson S.J. Proopiomelanocortin peptide immunocytochemistry in rhesus monkey brain. Brain Res Bull 1984, 13:785-800.
25. Khachaturian H., Watson S.J. Some perspectives on monoamine-opioid peptide interaction in rat central nervous system. Brain Res Bull 1982, 1-6:441-462.
26. Kreek M.J., Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 1998, 51:23-47.
27. Lee Y., Joe K., Sohn I., Na C., Kee B., Chae S. Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioid levels in nicotine dependence after naltrexone treatment. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:639-647.
28. Lkhider M., Delpal S., Le Provost F., Ollivier-Bousquet M. Rat prolactin synthesis by lactating mammary epithelial cells. FEBS Lett 1997, 401:117-122.
29. Mantsch J.R., Schlussman S.D., Ho A., Kreek M.J. Effects of cocaine self-administration on plasma corticosterone and prolactin in rats. J Pharmacol Exp Ther 2000, 294:239-247.
30. Marinelli M. Dopaminergic reward pathways and effects of stress. Stress Addict 2007, 41-83. Academic Press/Elsevier, London. M. al'Absi (Ed.).
31. Mathon D.S., Ramakers G.M., Pintar J.E., Marinelli M. Decreased firing frequency of midbrain dopamine neurons in mice lacking mu opioid receptors. Eur J Neurosci 2005, 21:2883-2886.
32. Meta T., Fujihara H., Kawasaki M., Hashimoto H., Saito T., Shibata M., Saito J., Oka T., Tsuji S., Onaka T., Ueta Y. Prolactin-releasing peptide is a potent mediator of stress responses in the brain through the hypothalamic paraventricular nucleus. Neuroscience 2006, 141(2):1069-1086.
33. Moore K.E., Demarest K.T., Lookingland K.J. Stress, prolactin, and hypothalamic dopaminergic neurons. Neuropharmacology 1987, 26:801-808.
34. Netter P., Toll C., Lujic C., Reuter M., Hennig J. Addictive and nonaddictive smoking as related to responsivity to neurotransmitter systems. Behav Pharmacol 2002, 13:441-449.
35. Patkar A.A., Hill K.P., Sterling R.C., Gottheil E., Berrettini W.H., Weinstein S.P. Serum prolactin and response to treatment among cocaine-dependent individuals. Addict Biol 2002, 7:45-53.
36. Pickworth W.B., Baumann M.H., Fant R.V., Rothman R.B., Henningfield J.E. Endocrine responses during acute nicotine withdrawal. Pharmacol Biochem Behav 1996, 55:433-437.
37. Reuter M., Henniq J. Cortisol as an indicator of dopaminergic effects on nicotine craving. Hum Psychopharmacol 2003, 18:437-446.
38. Rose J.E., Corrigall W.A. Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology (Berl) 1997, 130:28-40.
39. Salokangas R.K., Vilkman H., Ilonen T., Taiminen T., Bergman J., Haaparanta M., Solin O., Alanen A., Syvalahti E., Hietala J. High levels of dopamine activity in the basal ganglia of cigarette smokers. Am J Psychiatry 2000, 7:632-634.
40. Satel S.L., Price L.H., Palumbo J.M., McDougle C.J., Krystal J.H., Gawin F., Charney D.S., Heninger G.R., Kleber H.D. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 1991, 148:1712-1716.
41. Scott D.J., Domino E.F., Heitzeg M.M., Koeppe R.A., Ni L., Guthrie S., Zubieta J.K. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Neuropsychopharmacology 2007, 32:450-457.
42. Thomas G.B., Cummins J.T., Hammond J.M., Horton R.J., Clarke I.J. Prolonged secretion of prolactin in response to thyrotrophin-releasing hormone after hypothalamo-pituitary disconnection in the ewe. J Endocrinol 1986, 111(3):433-438.
43. Tupala E., Tiihonen J. Dopamine and alcoholism: neurological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1221-1247.
44. Vasey M.W., Thayer J.F. The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution. Psychophysiology 1987, 24:479-486.